Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Abstract
It is generally thought that many drug molecules are transported across biological membranes via passive diffusion at a rate related to their lipophilicity. However, the types of biophysical forces involved in the interaction of drugs with lipid membranes are no different from those involved in their interaction with proteins, and so arguments based on lipophilicity could also be applied to drug uptake by membrane transporters or carriers. In this article, we discuss the evidence supporting the idea that rather than being an exception, carrier-mediated and active uptake of drugs may be more common than is usually assumed - including a summary of specific cases in which drugs are known to be taken up into cells via defined carriers - and consider the implications for drug discovery and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Note that despite a widespread assumption that lipophilicity or log P is sufficient to account for drug distribution this is not in fact the case, as there are hundreds of natural transporters that drugs can use (e.g. [18,1714]).”
In the citing paper
“(Note that liophilicity per se may not be relevant, as drugs require carriers to cross membranes [18], and promiscuity and off-target effects increase with lipophilicity [1679].)”
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
CHEMIOSMOTIC COUPLING IN OXIDATIVE AND PHOTOSYNTHETIC PHOSPHORYLATION
MITCHELL, P. (1966) · Biological Reviews · doi:10.1111/j.1469-185x.1966.tb01501.x · Cited by 3,663
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 1×
“, do not obey the Ro5 (for example, most antibacterial”
BackgroundThe influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403 · cited 1×
“This is because many of the recent trends in molecular drug design and development have been towards increased lipophilicity, leading to a greater likelihood of both a lack of selectivity and of attritio”
BackgroundThe Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,246
Abraham, M. H. (1993) · Chemical Society Reviews · doi:10.1039/cs9932200073 · Cited by 1,968
Osmotic Stress Signaling and Osmoadaptation in Yeasts
Hohmann, S. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.300-372.2002 · Cited by 1,767
Research works printed but not linked: 1
- Jain, M. K. The Bimolecular Lipid Membrane. (Van Nostrand Reinhold, New York, 1972).
Cited by
Pharmacokinetics and drug metabolism in the elderly
Klotz, U. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902722679 · Cited by 826
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
The impact of natural products upon modern drug discovery
Ganesan, A. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.016 · Cited by 646
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
“Consequently, it would be interesting to discuss whether carrier-mediated transport is the ubiquitous and dominant mechanism of biological membrane permeation for most drugs in most organ”
BackgroundUnderstanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“Even determining the means of cell permeability and tissue distribution turns out to be a systems biology problem in which we need to know the nature and activity of all the carriers that are involved [1534; 1545; 1962].”
BackgroundSelf-citationNormal Mode Analysis of Biomolecular Structures: Functional Mechanisms of Membrane Proteins
Bahar, I., Lezon, T. R., Bakan, A., & Shrivastava, I. H. (2010) · Chemical Reviews · doi:10.1021/cr900095e · Cited by 537
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E., Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J., Ségaliny, A., et al. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0458-3 · Cited by 537
Prodrugs—from Serendipity to Rational Design
Huttunen, K. M., Raunio, H., & Rautio, J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003459 · Cited by 505
“Paradoxically, amino acid esters and amides can also be used to enhance absorption and consequently oral drug delivery of parent drugs, because the brush-border membrane of intestinal epithelium possesses a considerable number of transporters for amino acids and peptides (Majumdar et al., 2004; Dobson and Kell, 2008).”
BackgroundKell, D. B., Heyden, E. L., & Pretorius, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01221 · Cited by 460
Self-citationKell, D. B. (2011) · Annals of Botany · doi:10.1093/aob/mcr175 · Cited by 439
“Several relevant areas of the literature are thus bound up with each other, albeit (as in most fields; e.g. Hull et al., 2008; Dobson and Kell, 2008; Kell, 2009) that they have developed independently (the balkanization of the literature into ‘silos’).”
BackgroundSelf-citationPoynton, F. E., Bright, S. A., Blasco, S., Williams, D. C., Kelly, J. M., & Gunnlaugsson, T. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00680b · Cited by 421
Lead‐Oriented Synthesis: A New Opportunity for Synthetic Chemistry
Nadin, A., Hattotuwagama, C., & Churcher, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105840 · Cited by 390
Currin, A., Swainston, N., Day, P. J., & Kell, D. B. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00351a · Cited by 388
Self-citationA guide to plasma membrane solute carrier proteins
Pizzagalli, M. D., Bensimon, A., & Superti‐Furga, G. (2021) · The FEBS Journal · doi:10.1111/febs.15531 · Cited by 379
Rational Approaches to Improving Selectivity in Drug Design
Huggins, D. J., Sherman, W., & Tidor, B. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2010332 · Cited by 367
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“such disparate parts of the literature so as to draw out general truths (Dobson and Kell 2008; Kell 2009a), via the”
BackgroundMethodInfluentialSelf-citationAre bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?
Thwaites, G. E., & Gant, V. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2508 · Cited by 320
“Molecular size, charge and lipophilicity are all relevant to the ability of an antibiotic to penetrate cells, and drug-specific transmembrane transporters may operate for uptake as well as efflu”
Carpenter, T. S., Kirshner, D. A., Lau, E. Y., Wong, S. E., Nilmeier, J. P., & Lightstone, F. C. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.06.024 · Cited by 306
Cell permeability beyond the rule of 5
Matsson, P., Doak, B. C., Over, B., & Kihlberg, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.013 · Cited by 297
The biology of ergothioneine, an antioxidant nutraceutical
Borodina, I., Kenny, L. C., McCarthy, C. M., Paramasivan, K., Pretorius, E., Roberts, T. J., van der Hoek, S. A., & Kell, D. B. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422419000301 · Cited by 296
Self-citationBicker, J., Alves, G., Fortuna, A., & Falcão, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.012 · Cited by 262
Cell-penetrating peptides transport therapeutics into cells
Ramsey, J. D., & Flynn, N. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.003 · Cited by 256
Contaminants of emerging concern in a large temperate estuary
Meador, J. P., Yeh, A., Young, G., & Gallagher, E. P. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.01.088 · Cited by 237
“Active transport is likely an important mechanism to consider because a large number of drugs are known to be taken up across biological membranes by one of several known transporters (Dobson and Kell, 2008).”
BackgroundEvent extraction for systems biology by text mining the literature
Ananiadou, S., Pyysalo, S., Tsujii, J., & Kell, D. B. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.04.005 · Cited by 236
Self-citationDrug transporters of platinum-based anticancer agents and their clinical significance
Burger, H., Loos, W. J., Eechoute, K., Verweij, J., Mathijssen, R. H. J., & Wiemer, E. A. C. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.002 · Cited by 230
Szakács, G., Hall, M. D., Gottesman, M. M., Boumendjel, A., Kachadourian, R., Day, B. J., Baubichon-Cortay, H., & Di Pietro, A. (2014) · Chemical Reviews · doi:10.1021/cr4006236 · Cited by 203
Cecchini, C., Pannilunghi, S., Tardy, S., & Scapozza, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.672267 · Cited by 193
“PROTACs Uptake and Efflux It is generally accepted that passive transmembrane permeation represents the preferential route for cellular internalization of large-in-size compounds, however, the relative preponderance of passive cell permeability over transporter-mediated diffusion is affected by multiple factors and th…”
BackgroundIntrinsic Membrane Permeability to Small Molecules
Hannesschlaeger, C., Horner, A., & Pohl, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00560 · Cited by 194
Casini, A., & Reedijk, J. (2012) · Chemical Science · doi:10.1039/c2sc20627g · Cited by 196
Membrane transporter engineering in industrial biotechnology and whole cell biocatalysis
Kell, D. B., Swainston, N., Pir, P., & Oliver, S. G. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.02.001 · Cited by 194
Self-citationBuckton, L. K., Rahimi, M. N., & McAlpine, S. R. (2021) · Chemistry – A European Journal · doi:10.1002/chem.201905385 · Cited by 190
Nanoparticle mediated non-covalent drug delivery
Doane, T., & Burda, C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.05.012 · Cited by 188
“Subsequent release of the drug requires efficient uptake by the target cells, and these mechanisms have been explored in detail [99,100].”
BackgroundKell, D. B., Dobson, P. D., & Oliver, S. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.010 · Cited by 186
Self-citationCellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
Spreckelmeyer, S., Orvig, C., & Casini, A. (2014) · Molecules · doi:10.3390/molecules191015584 · Cited by 185
“only in the pharmacological effects, but also in determining side-effects, metabolism, and excretion of many drugs, including cisplatin and other cytotoxic metal compounds [14].”
BackgroundPlacental nutrient supply and fetal growth
Desforges, M., & Sibley, C. P. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082765md · Cited by 184
“Diffusional permeability of the placenta to hydrophilic molecules Hydrophilic molecules have poor solubility in lipid bilayers and therefore do not easily cross plasma membranes (Dobson and Kell, 2008).”
BackgroundThwaites, D. T., & Anderson, C. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01438.x · Cited by 180
“Rather, many drug molecules are transported across cell membranes in the human body via movement through a diverse range of carrier proteins each possessing a unique substrate selectivity and mode of action (Hagenbuch and Meier, 2003; Mizuno et al., 2003; Schinkel and Jonker, 2003; Koepsell et al., 2007; Thwaites and…”
BackgroundA Gestalt approach to Gram-negative entry
Silver, L. L. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.044 · Cited by 178
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
Winter, G. E., Radic, B., Mayor-Ruiz, C., Blomen, V. A., Trefzer, C., Kandasamy, R. K., Huber, K. V. M., Gridling, M., Chen, D., Klampfl, T., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1590 · Cited by 175
Kell, D. B., & Goodacre, R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.014 · Cited by 169
Self-citationYuan, H., Luo, K., Lai, Y., Pu, Y., He, B., Wang, G., Wu, Y., & Gu, Z. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1000923 · Cited by 166
In vivo, in vitro and in silico methods for small molecule transfer across the BBB
Mensch, J., Oyarzabal, J., Mackie, C., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21745 · Cited by 160
Larregieu, C. A., & Benet, L. Z. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9456-8 · Cited by 158
“Several recent articles have extensively elaborated on the importance, concepts, and problems of drug permeation across biological membranes in drug discovery, development, and regulatory evaluation (17,141,142).”
The influence of the 'organizational factor' on compound quality in drug discovery
Leeson, P. D., & St-Gallay, S. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3552 · Cited by 162
“and in governing interactions with drug transporter”
Evidence-based approach to assess passive diffusion and carrier-mediated drug transport
Di, L., Artursson, P., Avdeef, A., Ecker, G. F., Faller, B., Fischer, H., Houston, J. B., Kansy, M., Kerns, E. H., Krämer, S. D., et al. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.015 · Cited by 167
Mechanistic study on uptake and transport of pharmaceuticals in lettuce from water
Chuang, Y., Liu, C., Sallach, J. B., Hammerschmidt, R., Zhang, W., Boyd, S. A., & Li, H. (2019) · Environment International · doi:10.1016/j.envint.2019.104976 · Cited by 164
“However, large-sized molecules experience a slow diffusion rate through plant cell membranes hence retarding their accumulation in shoots (Di et al., 2012; Dobson and Kell, 2008; Kumar and Gupta, 2016; Trapp and Farlane, 1995).”
BackgroundKell, D. B., & Oliver, S. G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00231 · Cited by 156
“We have discussed the extensive literature of general anesthetics many times (Dobson and Kell, 2008; Dobson et al., 2009a,b; Kell and Dobson, 2009; Kell et al., 2011, 2013; Kell, 2013; Kell and Goodacre, 2014), and the available data show clearly the involvement of a variety of proteins such as…”
BackgroundInfluentialSelf-citationTemperature-Sensitive Polymersomes for Controlled Delivery of Anticancer Drugs
Liu, F., Kozlovskaya, V., Medipelli, S., Xue, B., Ahmad, F., Saeed, M. F., Cropek, D. M., & Kharlampieva, E. (2015) · Chemistry of Materials · doi:10.1021/acs.chemmater.5b03048 · Cited by 158
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
Huang, Q., Chen, Y., Zhang, W., Xia, X., Li, H., Qin, M., & Gao, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.054 · Cited by 167
Armitage, J. M., Erickson, R. J., Luckenbach, T., Ng, C. A., Prosser, R. S., Arnot, J. A., Schirmer, K., & Nichols, J. W. (2016) · Environmental Toxicology and Chemistry · doi:10.1002/etc.3680 · Cited by 147
“Membrane transporters play a critical role in determining the pharmacokinetics of some APIs in humans [40,41,43].”
BackgroundBauer, R. A., Wurst, J. M., & Tan, D. S. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.001 · Cited by 148
Kell, D. B., Dobson, P. D., Bilsland, E., & Oliver, S. G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.008 · Cited by 154
Self-citation‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries
Dobson, P. D., Patel, Y., & Kell, D. B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.011 · Cited by 144
Self-citationA widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs
Girardi, E., César-Razquin, A., Lindinger, S., Papakostas, K., Konecka, J., Hemmerich, J., Kickinger, S., Kartnig, F., Gürtl, B., Klavins, K., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0483-3 · Cited by 133
Tinworth, C. P., & Young, R. J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01596 · Cited by 141
Smith, D. A., Artursson, P., Avdeef, A., Di, L., Ecker, G. F., Faller, B., Houston, J. B., Kansy, M., Kerns, E. H., Krämer, S. D., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400713v · Cited by 154
Evidence for Drug Release from a Metalla‐Cage Delivery Vector Following Cellular Internalisation
Zava, O., Mattsson, J., Therrien, B., & Dyson, P. J. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200903216 · Cited by 127
The metabolome 18 years on: a concept comes of age
Kell, D. B., & Oliver, S. G. (2016) · Metabolomics · doi:10.1007/s11306-016-1108-4 · Cited by 158
“1987), drug transport (Dobson et al. 2009a; Dobson and Kell 2008; Kell 2013, 2015a, 2015b, 2016; Kell et al. 2013, 2011; Kell and Oliver 2014; Lanthaler et al. 2011; Mendes et al. 2015; O’Hagan and Kell 2015a) and biotech-”
BackgroundSelf-citationDahlgren, D., Roos, C., Sjögren, E., & Lennernäs, H. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24258 · Cited by 139
Kell, D. B. (2013) · The FEBS Journal · doi:10.1111/febs.12268 · Cited by 121
Self-citationRational Methods for the Selection of Diverse Screening Compounds
Huggins, D. J., Venkitaraman, A. R., & Spring, D. R. (2011) · ACS Chemical Biology · doi:10.1021/cb100420r · Cited by 118
“ignored by these filters is compounds that are substrates for drug transporters, which recent works suggests may be a significant proportion of molecules(34).”
BackgroundAlterations in drug disposition in older adults
Reeve, E., Wiese, M. D., & Mangoni, A. A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1004310 · Cited by 114
“While it was previously believed that the majority of drugs are absorbed via passive means, recent research indicates that carrier-mediated, active uptake of drugs may be more common than previously thought [43].”
BackgroundWatanabe, T., Kusuhara, H., & Sugiyama, Y. (2010) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-010-9176-y · Cited by 111
Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs
Joo, K., Liang, X., Liu, S., Liu, Y., Lee, C.-L., Conti, P. S., Wong, M. K. K., Li, Z., & Wang, P. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.039 · Cited by 113
“Endocytosis is generally considered one of the main entry mechanisms for various drug nanocarriers [28,29].”
BackgroundA ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs
O’Hagan, S., Swainston, N., Handl, J., & Kell, D. B. (2014) · Metabolomics · doi:10.1007/s11306-014-0733-z · Cited by 109
“…2001; van Deursen et al. 2011; Wunberg et al. 2006), and that successful drugs require or at least use membrane transporters (Dobson et al. 2009; Dobson and Kell 2008; Giacomini and Huang 2013; Giacomini et al. 2010; Kell 2013; Kell and Dobson 2009; Kell et al. 2013, 2011; Kell and Goodacre…”
BackgroundSelf-citationThe Time and Place for Nature in Drug Discovery
Young, R. J., Flitsch, S. L., Grigalunas, M., Leeson, P. D., Quinn, R. J., Turner, N. J., & Waldmann, H. (2022) · JACS Au · doi:10.1021/jacsau.2c00415 · Cited by 113
A Dormant Microbial Component in the Development of Preeclampsia
Kell, D. B., & Kenny, L. C. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00060 · Cited by 101
“because the necessary transporters [199-202] are absent.”
Self-citationMolecular Filters in Medicinal Chemistry
Kralj, S., Jukič, M., & Bren, U. (2023) · Encyclopedia · doi:10.3390/encyclopedia3020035 · Cited by 122
“Recent work also suggests that carriermediated transport and active-uptake may be more common than assumed [18,34].”
BackgroundYellepeddi, V., Kumar, A., & Palakurthi, S. (2009) · PubMed · Cited by 100
Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved
Li, R., Barton, H. A., & Varma, M. V. S. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0156-z · Cited by 103
“6) [63].”
The SuBliMinaL Toolbox: automating steps in the reconstruction of metabolic networks
Swainston, N., Smallbone, K., Mendes, P., Kell, D. B., & Paton, N. W. (2011) · Journal of Integrative Bioinformatics · doi:10.1515/jib-2011-186 · Cited by 97
“Transport reactions are important for both natural metabolites and xenobiotics [34,35].”
BackgroundSelf-citationHuttunen, J., Peltokangas, S., Gynther, M., Natunen, T., Hiltunen, M., Auriola, S., Ruponen, M., Vellonen, K.-S., & Huttunen, K. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49009-z · Cited by 96
O’Hagan, S., Muelas, M. W., Day, P. J., Lundberg, E. K., & Kell, D. B. (2018) · Cell Systems · doi:10.1016/j.cels.2018.01.003 · Cited by 103
“Transporters are also responsible for the uptake of pharmaceutical drugs and xenobiotics into cells, and their efflux therefrom (Colas et al., 2016; Dobson and Kell, 2008; Giacomini and Huang, 2013; Giacomini et al., 2010; Kell, 2015, 2016; Kell et al., 2011, 2013; Kell and Oliver, 2014; Lin et…”
BackgroundSelf-citationSantucci, P., Greenwood, D. J., Fearns, A., Chen, K., Jiang, H., & Gutierrez, M. G. (2021) · Nature Communications · doi:10.1038/s41467-021-24127-3 · Cited by 100
Hartinger, C. G., Phillips, A. D., & Nazarov, A. A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798040769 · Cited by 100
“The data suggest efficient release of the fluorescent cargo from its carrier after entry into the cell by assisted diffusion, an uptake mode reported also for platinum compounds [74-77].”
BackgroundMembrane Transporters as Mediators of Cisplatin Effects and Side Effects
Ciarimboli, G. (2012) · Scientifica · doi:10.6064/2012/473829 · Cited by 90
“therapeutic efficacy, and adverse drug reactions [1].”
Prediction of bioconcentration factors in fish and invertebrates using machine learning
Miller, T. H., Gallidabino, M. D., MacRae, J. I., Owen, S. F., Bury, N. R., & Barron, L. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.08.122 · Cited by 89
“For example, elimination and metabolism rates may impact net accumulation as well as more specific physiology such as carriermediated transport and protein binding (Dobson and Kell, 2008) will also influence accumulation, especially for emerging contaminant classes such as pharmaceuticals.”
BackgroundPretorius, E., Olumuyiwa-Akeredolu, O.-O. O., Soma, P., & Kell, D. B. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216681549 · Cited by 94
Self-citationDrug delivery: advancements and challenges
Singh, N., Joshi, A., Toor, A. P., & Verma, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00027-0 · Cited by 104
Svoboda, M., Wlcek, K., Taferner, B., Hering, S., Stieger, B., Castillo‐Tong, D. C., Zeillinger, R., Thalhammer, T., & Jäger, W. R. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.04.031 · Cited by 94
“However, uptake mechanisms into tumor cells might be even more important than efflux transporters for the efficacy of anticancer drugs because they are determinants for intracellular drug concentration [11].”
BackgroundTargeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles
Yang, Y.-S. S., Moynihan, K. D., Bekdemir, A., Dichwalkar, T., Noh, M. M., Watson, N., Melo, M. B., Ingram, J. R., Suh, H., Ploegh, H. L., et al. (2018) · Biomaterials Science · doi:10.1039/c8bm01208c · Cited by 90
Diffusion coefficients in ethanol and in water at 298K: Linear free energy relationships
Hills, E. E., Abraham, M. H., Hersey, A., & Bevan, C. (2011) · Fluid Phase Equilibria · doi:10.1016/j.fluid.2011.01.002 · Cited by 95
Dissecting Variability in Responses to Cancer Chemotherapy Through Systems Pharmacology
Yang, R., Niepel, M., Mitchison, T. K., & Sorger, P. K. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.96 · Cited by 85
Kell, D. B., & Pretorius, E. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.08.006 · Cited by 96
Self-citationReducing the Risk of Drug Attrition Associated with Physicochemical Properties
Leeson, P. D., & Empfield, J. R. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45024-1 · Cited by 85
The Fraction Dose Absorbed, in Humans, and High Jejunal Human Permeability Relationship
Dahan, A., Lennernäs, H., & Amidon, G. L. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300140h · Cited by 83
Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism
Joyce, H., McCann, A., CLYNES, M. M., & Larkin, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1028356 · Cited by 89
“Drug molecules can enter the cell by means of passive diffusion, endocytosis or facilitated transport [14].”
BackgroundKucińska, M., Skupin-Mrugalska, P., Szczołko, W., Sobotta, Ł., Sciepura, M., Tykarska, E., Wierzchowski, M., Teubert, A., Fedoruk‐Wyszomirska, A., Wyszko, E., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00052 · Cited by 82
Lanthaler, K., Bilsland, E., Dobson, P. D., Moss, H. J., Pir, P., Kell, D. B., & Oliver, S. G. (2011) · BMC Biology · doi:10.1186/1741-7007-9-70 · Cited by 84
“The importance of carriers in drug uptake has, until recently, been much overlooked in favor of the idea of drug uptake by diffusion through the lipid bilayer, despite persuasive arguments and extensive evidence to the contrary [60-65].”
ResultSelf-citationModeling Kinetics of Subcellular Disposition of Chemicals
Baláž, Š. (2009) · Chemical Reviews · doi:10.1021/cr030440j · Cited by 98
Baumeister, S., Wiesner, J., Reichenberg, A., Hintz, M., Bietz, S., Harb, O. S., Roos, D. S., Kordes, M., Friesen, J., Matuschewski, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019334 · Cited by 88
“from the apicoplast; [13]) in their chemical libraries (in contrast to the current situation; see [47,48] for a general discussion).”
BackgroundImplications of the Dominant Role of Transporters in Drug Uptake by Cells (Supplementary Material)
Dobson, P. D., Lanthaler, K., Oliver, S. G., & Kell, D. B. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609787521616 · Cited by 94
“However, artificial membranes are not entirely without utility for predicting drug transport across membranes (although close inspection of recent results reveals that artificial membrane results might not be quite as useful as claimed, see figures 2-3 in [1]).”
BackgroundInfluentialSelf-citationBrain uptake of ketoprofen–lysine prodrug in rats
Gynther, M., Jalkanen, A. J., Lehtonen, M., Forsberg, M., Laine, K., Ropponen, J., Leppänen, J., Knuuti, J., & Rautio, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.019 · Cited by 79
Role of organic cation transporters in drug-induced toxicity
Ciarimboli, G. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.547474 · Cited by 78
“However, it is becoming evident that membrane transporters are also important determinants of in vivo drug disposition, therapeutic efficacy and adverse drug reactions [1].”
BackgroundOrthosteric versus allosteric GPCR activation: The great challenge of group-III mGluRs
Flor, P. J., & Acher, F. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.013 · Cited by 89
Extracellular Acid-Base Balance and Ion Transport Between Body Fluid Compartments
Seifter, J. L., & Chang, H.-Y. (2017) · Physiology · doi:10.1152/physiol.00007.2017 · Cited by 103
“Because of new genomic classification of transporters involved in disease, and because of drug design capable of targeting these transporters, new therapies may become available (16, 18).”
BackgroundLeitstruktur‐orientierte Synthese: eine Alternative für die Synthesechemie
Nadin, A. J., Hattotuwagama, C. K., & Churcher, I. (2012) · Angewandte Chemie · doi:10.1002/ange.201105840 · Cited by 75
Event-based text mining for biology and functional genomics
Ananiadou, S., Thompson, P., Nawaz, R., McNaught, J., & Kell, D. B. (2014) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu015 · Cited by 77
Self-citationStrategies for transitioning macrocyclic peptides to cell-permeable drug leads
Walport, L. J., Obexer, R., & Suga, H. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.07.007 · Cited by 77
Neumaier, F., Zlatopolskiy, B. D., & Neumaier, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101542 · Cited by 86
“The latter is usually regarded as the most important pathway for penetration of small molecule-based drugs into the CNS, although there is some evidence that the role of specific transporters may be more significant than previously thought [34].”
Background
Metadata
- Authors
- Dobson, P. D., & Kell, D. B.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Kell, Douglas B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-03
- Volume
- 7
- Issue
- 3
- Pages
- 205-220
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2157619122
- Cited by
- 475
- References
- 265
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 20 · 2023: 19 · 2022: 18 · 2021: 24 · 2020: 27 · 2019: 20 · 2018: 17 · 2017: 28 · 2016: 36 · 2015: 43 · 2014: 42 · 2013: 29 · 2012: 36
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Royal Society
- Wolfson Foundation
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council (747/1, BB/D007)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- passive diffusion, lipophilicity, membrane transporters, drug discovery, drug development
- MeSH terms
- Animals, Biological Transport, Cell Membrane, Cell Membrane Permeability, Pharmaceutical Preparations, Humans, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.